Real-life experiences with galcanezumab and predictors for treatment response in Turkey.

MLA

Yalinay Dikmen, Pınar, et al. “Real-Life Experiences with Galcanezumab and Predictors for Treatment Response in Turkey.” BMC Neurology, vol. 23, no. 1, Nov. 2023, pp. 1–13. EBSCOhost, https://doi.org/10.1186/s12883-023-03467-1.

APA

Yalinay Dikmen, P., Baykan, B., Uludüz, D., Özge, A., Ilgaz Aydınlar, E., Polat, B., Karlı, N., Tepe, N., Çelebisoy, N., Ergin Toktaş, H., Niflioğlu, B., Karacı, R., Mayda Domaç, F., Uludüz, E., Erdogan Soyukibar, T., Öksüz, N., & Ertaş, M. (2023). Real-life experiences with galcanezumab and predictors for treatment response in Turkey. BMC Neurology, 23(1), 1–13. https://doi.org/10.1186/s12883-023-03467-1

Chicago

Yalinay Dikmen, Pınar, Betül Baykan, Derya Uludüz, Aynur Özge, Elif Ilgaz Aydınlar, Burcu Polat, Necdet Karlı, et al. 2023. “Real-Life Experiences with Galcanezumab and Predictors for Treatment Response in Turkey.” BMC Neurology 23 (1): 1–13. doi:10.1186/s12883-023-03467-1.